Chemokine CXCL2
"Chemokine CXCL2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A CXC chemokine that is synthesized by activated MONOCYTES and NEUTROPHILS. It has specificity for CXCR2 RECEPTORS.
Descriptor ID |
D054426
|
MeSH Number(s) |
D12.644.276.374.200.120.100 D12.644.276.374.200.600.940 D12.776.467.374.200.120.100 D12.776.467.374.200.600.940 D23.125.300.120.100 D23.125.300.600.940 D23.469.200.120.100 D23.469.200.600.940 D23.529.374.200.120.100 D23.529.374.200.600.940
|
Concept/Terms |
Chemokine CXCL2- Chemokine CXCL2
- CXCL2, Chemokine
- LDNCF-2
- Macrophage Inflammatory Protein 2
- Macrophage Inflammatory Protein-2alpha
- Inflammatory Protein-2alpha, Macrophage
- Macrophage Inflammatory Protein 2alpha
- Chemokine (C-X-C Motif) Ligand 2
- MIP-2alpha
- MIP 2alpha
- MIP2alpha
- CXCL2 Chemokine
- Chemokine, CXCL2
- MIP-2 Chemokine
- Chemokine, MIP-2
- MIP 2 Chemokine
|
Below are MeSH descriptors whose meaning is more general than "Chemokine CXCL2".
Below are MeSH descriptors whose meaning is more specific than "Chemokine CXCL2".
This graph shows the total number of publications written about "Chemokine CXCL2" by people in this website by year, and whether "Chemokine CXCL2" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 0 | 2 | 2 | 1998 | 0 | 1 | 1 | 1999 | 0 | 1 | 1 | 2000 | 0 | 2 | 2 | 2001 | 0 | 1 | 1 | 2002 | 0 | 4 | 4 | 2003 | 0 | 1 | 1 | 2004 | 0 | 2 | 2 | 2006 | 0 | 2 | 2 | 2007 | 0 | 2 | 2 | 2009 | 0 | 1 | 1 | 2010 | 0 | 3 | 3 | 2011 | 0 | 2 | 2 | 2014 | 0 | 2 | 2 | 2015 | 0 | 1 | 1 | 2017 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Chemokine CXCL2" by people in Profiles.
-
Ruebel ML, Cotter M, Sims CR, Moutos DM, Badger TM, Cleves MA, Shankar K, Andres A. Obesity Modulates Inflammation and Lipid Metabolism Oocyte Gene Expression: A Single-Cell Transcriptome Perspective. J Clin Endocrinol Metab. 2017 06 01; 102(6):2029-2038.
-
Murphy PS, Wang J, Bhagwat SP, Munger JC, Janssen WJ, Wright TW, Elliott MR. CD73 regulates anti-inflammatory signaling between apoptotic cells and endotoxin-conditioned tissue macrophages. Cell Death Differ. 2017 03; 24(3):559-570.
-
Shults JA, Curtis BJ, Chen MM, O'Halloran EB, Ramirez L, Kovacs EJ. Impaired respiratory function and heightened pulmonary inflammation in episodic binge ethanol intoxication and burn injury. Alcohol. 2015 Nov; 49(7):713-20.
-
Ronis MJ, Mercer KE, Gannon B, Engi B, Zimniak P, Shearn CT, Orlicky DJ, Albano E, Badger TM, Petersen DR. Increased 4-hydroxynonenal protein adducts in male GSTA4-4/PPAR-a double knockout mice enhance injury during early stages of alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol. 2015 Mar 01; 308(5):G403-15.
-
Fang WF, Douglas IS, Wang CC, Kao HC, Chang YT, Tseng CC, Huang KT, Chang HC, Lin MC. 5-Lipoxygenase activating protein (FLAP) dependent leukotriene biosynthesis inhibition (MK591) attenuates Lipid A endotoxin-induced inflammation. PLoS One. 2014; 9(7):e102622.
-
Reiner AP, Lettre G, Nalls MA, Ganesh SK, Mathias R, Austin MA, Dean E, Arepalli S, Britton A, Chen Z, Couper D, Curb JD, Eaton CB, Fornage M, Grant SF, Harris TB, Hernandez D, Kamatini N, Keating BJ, Kubo M, LaCroix A, Lange LA, Liu S, Lohman K, Meng Y, Mohler ER, Musani S, Nakamura Y, O'Donnell CJ, Okada Y, Palmer CD, Papanicolaou GJ, Patel KV, Singleton AB, Takahashi A, Tang H, Taylor HA, Taylor K, Thomson C, Yanek LR, Yang L, Ziv E, Zonderman AB, Folsom AR, Evans MK, Liu Y, Becker DM, Snively BM, Wilson JG. Genome-wide association study of white blood cell count in 16,388 African Americans: the continental origins and genetic epidemiology network (COGENT). PLoS Genet. 2011 Jun; 7(6):e1002108.
-
Waseda K, Miyahara N, Kanehiro A, Ikeda G, Koga H, Fuchimoto Y, Kurimoto E, Tanimoto Y, Kataoka M, Tanimoto M, Gelfand EW. Blocking the leukotriene B4 receptor 1 inhibits late-phase airway responses in established disease. Am J Respir Cell Mol Biol. 2011 Oct; 45(4):851-7.
-
Liu Y, Mei J, Gonzales L, Yang G, Dai N, Wang P, Zhang P, Favara M, Malcolm KC, Guttentag S, Worthen GS. IL-17A and TNF-a exert synergistic effects on expression of CXCL5 by alveolar type II cells in vivo and in vitro. J Immunol. 2011 Mar 01; 186(5):3197-205.
-
Mendez MP, Monroy YK, Du M, Preston AM, Tolle L, Lin Y, VanDussen KL, Samuelson LC, Standiford TJ, Curtis JL, Beck JM, Christensen PJ, Paine R. Overexpression of sICAM-1 in the alveolar epithelial space results in an exaggerated inflammatory response and early death in Gram negative pneumonia. Respir Res. 2011 Jan 19; 12:12.
-
Bermudez DM, Xu J, Herdrich BJ, Radu A, Mitchell ME, Liechty KW. Inhibition of stromal cell-derived factor-1a further impairs diabetic wound healing. J Vasc Surg. 2011 Mar; 53(3):774-84.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|